Literature DB >> 16055807

Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment.

Andreas Bechdolf1, Stephan Ruhrmann, Michael Wagner, Kai Uwe Kühn, Birgit Janssen, Ronald Bottlender, Anke Wieneke, Frauke Schulze-Lutter, Wolfgang Maier, Joachim Klosterkötter.   

Abstract

BACKGROUND: The Early Detection and Intervention Programme of the German Research Network on Schizophrenia (GRNS) investigates the initial prodromal phase of psychosis in a multidimensional approach. Two intervention strategies are being studied by two large-scale multicentre projects. AIMS: To present the concept of the intervention studies, and to provide an interim report of the recruitment procedure.
METHOD: Comprehensive cognitive-behavioural therapy has been developed for patients in the "early initial prodromal state". For patients in the "late initial prodromal state" the atypical neuroleptic amisulpride is explored. Both interventions are evaluated in randomised controlled trials using clinical management as the control condition.
RESULTS: Between January 2001 and March 2003, 1212 individuals seeking help for mental health problems were screened for putative prodromal symptoms at four university centres. More than 388 individuals fulfilled criteria for both interventions and 188 (48.5%) gave informed consent to participate in the trials.
CONCLUSIONS: The screening procedure appears to be feasible and trial participation seems to be acceptable to a relevant proportion of people at increased risk of developing psychosis.

Entities:  

Mesh:

Year:  2005        PMID: 16055807     DOI: 10.1192/bjp.187.48.s45

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  20 in total

1.  Recent approaches to psychological interventions for people at risk of psychosis.

Authors:  Andreas Bechdolf; Lisa J Phillips; Shona M Francey; Steven Leicester; Anthony P Morrison; Verena Veith; Joachim Klosterkötter; Patrick D McGorry
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-04       Impact factor: 5.270

Review 2.  Intervention in at-risk states for developing psychosis.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Andreas Bechdolf; Joachim Klosterkötter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-10-14       Impact factor: 5.270

Review 3.  Assessment of adolescents at risk for psychosis.

Authors:  Karin Borgmann-Winter; Monica E Calkins; Kathryn Kniele; Raquel E Gur
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

4.  Recruitment and treatment practices for help-seeking "prodromal" patients.

Authors:  Thomas H McGlashan; Jean Addington; Tyrone Cannon; Markus Heinimaa; Patrick McGorry; Mary O'Brien; David Penn; Diana Perkins; Raimo K R Salokangas; Barbara Walsh; Scott W Woods; Alison Yung
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

Review 5.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

6.  The clinical staging and the endophenotype approach as an integrative future perspective for psychiatry.

Authors:  Joachim Klosterkötte
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

7.  Neurophysiological correlates of impaired facial affect recognition in individuals at risk for schizophrenia.

Authors:  Wolfgang Wölwer; Jürgen Brinkmeyer; Sanna Stroth; Marcus Streit; Andreas Bechdolf; Stephan Ruhrmann; Michael Wagner; Wolfgang Gaebel
Journal:  Schizophr Bull       Date:  2011-03-14       Impact factor: 9.306

8.  Use of Palm computer as an adjunct to cognitive-behavioural therapy with an ultra-high-risk patient: a case report.

Authors:  David Kimhy; Cheryl Corcoran
Journal:  Early Interv Psychiatry       Date:  2008-11       Impact factor: 2.732

9.  Indicated prevention of schizophrenia.

Authors:  Joachim Klosterkötter
Journal:  Dtsch Arztebl Int       Date:  2008-07-25       Impact factor: 5.594

10.  Update on the management of symptoms in schizophrenia: focus on amisulpride.

Authors:  Ann M Mortimer
Journal:  Neuropsychiatr Dis Treat       Date:  2009-05-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.